 |
市场调查报告书
商品编码
1373842
全球药物筛选市场（2023-2030）：按类型（酒精/大麻）和最终用户（药物测试/职场）分類的规模、份额、成长分析和预测Global Drug Screening Market Size, Share, Growth Analysis, By Type(Alcohol, Cannabis), By End-User(Drug testing laboratories and Workplaces) - Industry Forecast 2023-2030 |
||||||
全球药物筛选市场规模将从2021年的53亿美元成长到2022年的62.2亿美元，预测期内年复合成长率为17.3%，预计到2030年将达到261.5亿美元。
全球药物筛检市场是医疗保健产业中快速成长的细分市场，其重点是检测个体中是否存在药物或其代谢物。药物筛检在各种环境中发挥重要作用，包括职场、医院、体育组织和执法部门，帮助识别可能使用非法药物或滥用处方药的个人。这个市场是由几个因素所驱动的。首先，世界各地药物滥用和成瘾现像日益普遍，对有效的筛检方法产生了巨大的需求。世界各地的政府和组织越来越意识到药物滥用的社会和经济影响，导致强制进行药物检测的法规和政策增加。全球药物筛检市场的另一个主要驱动因素是公司越来越重视职场安全和越来越多地实施无毒品政策。雇主越来越认识到维持无毒品职场环境的重要性，以确保员工生产力、减少事故并最大限度地减少法律责任。
本报告调查了全球药物筛选市场，并提供了市场概况、市场各种影响因素分析、技术和创新趋势、法律制度、市场规模趋势和预测，以及按各个细分市场和地区进行的细分。竞争形势、主要企业概况等
目录
- 执行摘要
- 调查方法
- 母市场分析
- 市场概况
- 市场规模
- 市场动态
- 促进因素
- 机会
- 抑制因素
- 任务
- 关键市场洞察
- 技术分析
- 价格分析
- 供应链分析
- 价值链分析
- 市场生态系统
- 智慧财产权分析
- 贸易分析
- 启动分析
- 原料分析
- 创新矩阵
- 研发线产品分析
- 总体经济指标
- 重点投资分析
- 关键成功因素
- 竞争程度
- 市场动态及展望
- 市场动态
- 促进因素
- 机会
- 抑制因素
- 任务
- 市场动态
- 法规状况
- 波特的分析
- Skyquest 对未来颠覆的独家见解
- 全球药物筛选市场：按类型
- 市场概况
- 酒精
- 大麻
- 古柯碱
- 阿片类药物
- 安非他命/甲基安非他明
- LSD
- 全球药物筛选市场：依最终用户分类
- 市场概况
- 药物检测实验室
- 职场
- 全球药物筛选市场：按地区
- 市场概况
- 北美洲
- 欧洲
- 亚太地区
- 拉丁美洲
- 中东/非洲
- 竞争形势
- 前5名企业对比
- 主要企业市场地位
- 主要企业的招募策略
- 关键成功策略
- 近期市集活动
- 主要企业市场占有率
- 主要企业简介
- LabCorp
- Quest Diagnostic
- Abbott
- Thermo Fisher Scientific, Inc.
- Alfa Scientific Designs, Inc.
- OraSure Technologies, Inc.
- Siemens
- F. Hoffmann-La Roche Ltd
- MPD Inc.
- Shimadzu Corporation
- Lifeloc Technologies, Inc
- Dragerwerk AG & Co. KGaA
- Premier Biotech, Inc.
- Omega Laboratories, Inc. (US)
- Psychemedics Corporation (US)
- Clinical Reference Laboratory Inc., (US)
- American Bio Medica Corporation (US)
- Company Overview
- Sciteck, Inc.
- Synens SAS
Global Drug Screening Market size was valued at USD 5.3 billion in 2021 and is poised to grow from USD 6.22 billion in 2022 to USD 26.15 billion by 2030, growing at a CAGR of 17.3% during the forecast period (2023-2030).
The global drug screening market is a rapidly growing sector within the healthcare industry that focuses on detecting the presence of drugs or their metabolites in individuals. Drug screening plays a crucial role in various settings, including workplaces, hospitals, sports organizations, and law enforcement agencies, as it helps identify individuals who may be using illicit substances or misusing prescription drugs. The market is driven by several factors. First and foremost, the rising prevalence of drug abuse and addiction worldwide has created a significant demand for effective screening methods. Governments and organizations across the globe are increasingly recognizing the social and economic impact of drug abuse, leading to stricter regulations and policies that require drug testing. Another key driver for the global drug screening market is the increasing emphasis on workplace safety and the implementation of drug-free policies by companies. Employers are increasingly realizing the importance of maintaining a drug-free work environment to ensure employee productivity, reduce accidents, and minimize legal liabilities. In conclusion, the global market is experiencing significant growth driven by factors such as the increasing prevalence of drug abuse, technological advancements, workplace safety initiatives, and sports industry requirements. As drug screening becomes more crucial in various sectors, the market is expected to continue expanding in the coming years, with ongoing advancements in testing methods and regulations playing a pivotal role in shaping its future.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Drug Screening Market Segmental Analysis
Global Drug Screening Market is segmented by type, end-user, and region. Based on type, the market can be segmented into Alcohol, Cannabis, Cocaine, Opioids, Amphetamine and Methamphetamine, and LSD. Based on end-user, the market is segmented into drug test laboratories and workplaces. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Drug Screening Market Dynamics
Drivers of the Global Drug Screening Market
Growing Drugs Consumption
As drug screening products and services are increasingly used on the road, it is anticipated that the expanding use of illicit drugs will also hasten the market's overall expansion. Additionally, teen drug use will support market expansion. Additionally, the screening is simple to put into practise, providing flexible and successful workplace drug testing, which is also anticipated to support market expansion. One important element that is anticipated to temper the market's expansion is the rise in government spending to combat drug trafficking. Future drug screening market growth will be further accelerated by the rise in traffic accidents brought on by drugged driving and prescription medication abuse.
Restraints in the Global Drug Screening Market
Prohibition of Drug Testing
Drug testing is viewed as a violation of employee privacy in some settings, particularly the workplace, which is predicted to slow market expansion. The drug screening business is expected to be challenged by restrictions on drug use in some locations and problems with breathalyser accuracy.
Market Trends of Global Drug Screening Key
The global drug screening market is witnessing several key market trends that are shaping its growth and trajectory. Firstly, there is a growing adoption of advanced technologies in drug screening. This includes the development of more sensitive and accurate testing methods, such as liquid chromatography-mass spectrometry (LC-MS) and immunoassays, which enhance the detection capabilities of drug screening procedures. Another significant trend is the increasing focus on oral fluid drug testing. Saliva-based drug screening offers non-invasive sample collection and provides a convenient alternative to urine and blood tests. It has a shorter detection window but offers real-time drug use detection and is particularly valuable in post-accident and roadside testing scenarios. Overall, the key market trends in the drug screening industry revolve around advanced technologies, rapid on-site testing, oral fluid testing, expanded drug panels, and the integration of AI and ML. These trends reflect the industry's continuous efforts to enhance accuracy, convenience, and efficiency in drug screening processes.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Drug Screening Market by Type
- Market Overview
- Alcohol
- Cannabis
- Cocaine
- Opioids
- Amphetamine and Methamphetamine
- and LSD
- Global Drug Screening Market by End-User
- Market Overview
- Drug testing laboratories and Workplaces
- Global Drug Screening Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- LabCorp (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Quest Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Alfa Scientific Designs, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OraSure Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MPD Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lifeloc Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dragerwerk AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Premier Biotech, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Omega Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Psychemedics Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Clinical Reference Laboratory Inc., (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- American Bio Medica Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ACM Global Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sciteck, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Synens SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
